Published in Eur J Pharmacol on February 01, 1976
Central and Peripheral GABA(A) Receptor Regulation of the Heart Rate Depends on the Conscious State of the Animal. Adv Pharmacol Sci (2011) 0.76
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis (1983) 4.42
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob Agents Chemother (1982) 3.91
The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol (1988) 2.96
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Prospective study of blunt aortic injury: Multicenter Trial of the American Association for the Surgery of Trauma. J Trauma (1997) 2.60
On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol (1991) 2.49
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci U S A (1999) 2.42
Personal health records: an evaluation. Arch Dis Child (1987) 2.32
Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol. Nature (1975) 2.23
Changing use of hospital beds by the elderly. Br Med J (1968) 2.18
Na-Ca exchange and tension development in arterial smooth muscle. Philos Trans R Soc Lond B Biol Sci (1973) 2.07
Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther (1972) 1.94
Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology (1991) 1.73
Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial. Lancet (1980) 1.73
Functional consequences of engagement of the T cell receptor by low affinity ligands. J Immunol (1993) 1.70
Central adrenergic neurones and the initiation and development of experimental hypertension. Experientia (1972) 1.67
The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. Biochem Biophys Res Commun (1988) 1.65
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy (1982) 1.58
Pharmacology of midazolam. Arzneimittelforschung (1981) 1.52
Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method. Eye (Lond) (1997) 1.50
Chemical sympathectomy of the cat with 6-hydroxydopamine. J Pharmacol Exp Ther (1969) 1.46
Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology (1999) 1.42
Distal revascularisation with interval ligation (DRIL): an experience. Ann R Coll Surg Engl (2009) 1.41
Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol (1974) 1.40
Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol (1979) 1.40
Reducing maternal smoking and relapse: long-term evaluation of a pediatric intervention. Prev Med (1997) 1.40
The clinical and computed tomographic features of cerebellar peduncular hemorrhage. Neurology (1988) 1.38
Predictors of smoking during and after pregnancy: a survey of mothers of newborns. Prev Med (1995) 1.37
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol Oncol (1997) 1.30
Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. Br J Pharmacol (1973) 1.25
Taxonomy and identification of mucormycosis-causing fungi. I. Synonymity of Absidia ramosa with A. corymbifera. Sabouraudia (1974) 1.23
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. J Immunol (1992) 1.20
Penetrating esophageal injuries: multicenter study of the American Association for the Surgery of Trauma. J Trauma (2001) 1.19
Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology (1998) 1.19
Protective isolation in single-bed rooms: studies in a modified hospital ward. J Hyg (Lond) (1971) 1.19
Cyclic adenosine monophosphate: potassium-dependent action on vascular smooth muscle membrane potential. Science (1970) 1.16
Differential effects of prazosin on the pre- and postsynaptic alpha-adrenoceptors in the rat and dog [proceedings]. Br J Pharmacol (1977) 1.15
On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn Schmiedebergs Arch Pharmakol (1969) 1.15
Effects of prazosin and phentolamine on cardiac presynaptic alpha-adrenoceptors in the cat, dog and rat. Clin Exp Hypertens (1978) 1.15
Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology (2008) 1.15
The DNA sequence and comparative analysis of human chromosome 10. Nature (2004) 1.14
Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin. J Biol Chem (1984) 1.13
Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol (1998) 1.13
Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol (1978) 1.13
Effects of tetraethylammonium chloride on contractile, membrane and cable properties of rabbit artery muscle. J Physiol (1980) 1.11
Pre- and postjunctional supersensitivity of the mesenteric artery preparation from normotensive and hypertensive rats. Naunyn Schmiedebergs Arch Pharmakol (1970) 1.11
Early pre- and postjunctional effects of 6-hydroxydopamine. J Pharmacol Exp Ther (1971) 1.09
Differential patterns of executive function in children with attention-deficit hyperactivity disorder according to gender and subtype. J Child Neurol (1999) 1.09
Cardiovascular effects of prazosin in dogs. Clin Sci Mol Med Suppl (1976) 1.09
Bilateral tracheal bronchi. J Pediatr Surg (1986) 1.08
Characterization of [3H]nifedipine binding sites in rabbit myocardium. Eur J Pharmacol (1982) 1.07
Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes. Pflugers Arch (1989) 1.07
Noradrenaline contractions in rabbit mesenteric arteries skinned with saponin. J Physiol (1981) 1.07
Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings]. Br J Pharmacol (1979) 1.06
A new approach for dealing with the stability of drugs in biological fluids. J Pharm Sci (1985) 1.06
Experimental hypertension of the rat: reciprocal changes of norepinephrine turnover in heart and brain-stem. Naunyn Schmiedebergs Arch Pharmakol (1971) 1.05
Cilazapril prevents hypertension in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1986) 1.05
The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J Cardiovasc Pharmacol (1993) 1.04
The one-and-a-half syndrome--a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature. Neurology (1983) 1.03
The pharmacology of prazosin, a novel antihypertensive agent. Life Sci (1980) 1.03
Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.03
Differential interactions of clonidine and methoxamine with the postsynaptic alpha-adrenoceptor of rabbit main pulmonary artery. J Cardiovasc Pharmacol (1983) 1.02
Relationship between noradrenaline-induced depolarization and contraction in vascular smooth muscle. Blood Vessels (1978) 1.02
Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.02
Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Clin Exp Hypertens A (1987) 1.01
Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol (1987) 1.01
Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs. Circ Res (1975) 1.01
Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther (1982) 1.00
Normal aging effects for frequency doubling technology perimetry. Optom Vis Sci (1999) 0.99
The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer". J Cardiovasc Pharmacol (1991) 0.99
Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation (1992) 0.99
Risk factors for work related violence in a health care organization. Inj Prev (2004) 0.98
The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther (1991) 0.98
Risk moderation of parent and child outcomes in a preventive intervention: a test and replication. Am J Orthopsychiatry (1998) 0.98
Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol (1983) 0.98
The cardiovascular effects of apomorphine in the anaesthetized rat. Eur J Pharmacol (1973) 0.97
Measurement of blood pressure in unanaesthetized rats and mice. Arzneimittelforschung (1968) 0.96
Automated perimetry in amblyopia: a generalized depression. Am J Ophthalmol (1999) 0.96
A GIS-based methodology for selecting stormwater disconnection opportunities. Water Sci Technol (2012) 0.95
Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: Subclassification and functional description. Life Sci (1982) 0.95
K+ channel openers and 'natural' cardioprotection. Trends Pharmacol Sci (1992) 0.95
alpha 2-Adrenoceptors in rat resistance vessels. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.95
"Calcium antagonists": a class of drugs with a bright future. Part II. Determination of basic pharmacological properties. Life Sci (1984) 0.95
Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs. J Cardiovasc Pharmacol (1986) 0.94
Effects of adenosine 3' : 5'-monophosphate and guanosine 3' : 5'-monophosphate on calcium uptake and phosphorylation in membrane fractions of vascular smooth muscle. Biochim Biophys Acta (1978) 0.94
Contrast sensitivity testing in pseudotumor cerebri. Ophthalmology (1986) 0.93
Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration. J Pharmacol Exp Ther (1990) 0.93
Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. J Pharmacol Exp Ther (1990) 0.93
Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res (1994) 0.93
The structure of Escherichia coli heat-stable enterotoxin b by nuclear magnetic resonance and circular dichroism. Protein Sci (1995) 0.92
Threshold Amsler grid testing. Cross-polarizing lenses enhance yield. Arch Ophthalmol (1986) 0.92
The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks [proceedings]. Br J Pharmacol (1978) 0.92
Time-course analysis of the cardiovascular effects of clonidine resulting from the activation of cardiac pre- and vascular postsynaptic alpha-adrenoceptors in the pithed rat [proceedings]. Br J Pharmacol (1978) 0.92
Source of immunization of infants. Med J Aust (1987) 0.91